Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Completed

Conditions studied: Age Related Macular Degeneration, Choroidal Neovascularization, Central Serous Chorioretinopathy

In brief

The study will be designed as a case control evaluation to compare the genetic profiles of three groups of patients categorized according to diagnosis. Group 1 - CNV secondary to CSC Group 2 - CSC without CNV Group 3 - CNV secondary to advanced AMD.

Key facts

Study ID

NCT01880788

Run by

Sequenom, Inc.

People needed

152

Starts

2012-11-01

Expected to finish

2015-08-01

Last updated by the study team

2015-09-18

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Caucasian
• 30 years and older (CSC)
• 50 years and older (Advanced AMD)
• Genders Eligible for Study: Both
• Completed Consent form
• Diagnosis of choroidal neovascularization in at least one eye

You may not qualify if…

• Patient age less than 30 years (CSC).
• Patient age less than 50 years (AMD).
• Presence of retinal disease involving the photoreceptors and/or outer retinal layers other than AMD and CSC such as high myopia, retinal dystrophies, retinal vein occlusion, diabetic retinopathy and uveitis or similar outer retinal diseases which have been present prior to the age of 30.
• Opacities of the ocular media, limitations of pupillary dilation or other problems sufficient to preclude adequate fundus photography.
• Missing informed consent
• Previous sample donation under this protocol

Where it is running

• Vitreous Retina Macula Consultants of New York — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.